Cart
sales@molnova.com
Anti-inflammatory agent 42
CAS No. 877468-30-9
Anti-inflammatory agent 42( —— )
Catalog No. M36629 CAS No. 877468-30-9
Anti-inflammatory agent 42 has anti-inflammatory activity and inhibits the expression of TNF-α and IL-6 in LPS-stimulated macrophages.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 56 | In Stock |
|
| 10MG | 90 | In Stock |
|
| 25MG | 145 | In Stock |
|
| 50MG | 214 | In Stock |
|
| 100MG | 313 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAnti-inflammatory agent 42
-
NoteResearch use only, not for human use.
-
Brief DescriptionAnti-inflammatory agent 42 has anti-inflammatory activity and inhibits the expression of TNF-α and IL-6 in LPS-stimulated macrophages.
-
DescriptionAnti-inflammatory agent 42 (Compound 10j) is an anti-inflammatory agent. Anti-inflammatory agent 42 shows excellent inhibition on the expression of TNF-α and IL-6 in LPS (HY-D1056)-stimulated macrophages.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetIL Receptor
-
RecptorIL Receptor | TNF
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number877468-30-9
-
Formula Weight328.39
-
Molecular FormulaC20H12N2OS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1N2C(S\C1=C/C1=C3C=CC=CC3=CC=C1)=NC1=C2C=CC=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Hu J, et al. Synthesis and biological evaluation of novel thiazolidinone derivatives as potential anti-inflammatory agents. Eur J Med Chem. 2013 Jun;64:292-301.?
molnova catalog
related products
-
Ac-YVAD-CMK
Ac-YVAD-CMK (Ac-Tyr-Val-Ala-Asp-CMK) is a selective and irreversible inhibitor of Caspase-1 and inhibits pyroptosis, IL-1β and IL-18. Ac-YVAD-CMK shows neuroprotective and anti-inflammatory capacity.
-
5-O-Caffeoylshikimic...
5-O-Caffeoylshikimic acid shows anti-oxidative activity; it also shows anti-inflammatory activity, the underlying mechanism was associated with downregulation of nuclear factor-κB.
-
Reslizumab
Reslizumab (Sch 55700) is a humanized immunoglobulin G (IgG)4 κ monoclonal antibody that binds to human interleukin 5, thereby decreasing eosinophil production and survival.
